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BACKGROUND: Alcohol intake has consistently been associated with increased breast cancer incidence in epidemiological studies.
However, the relation between alcohol and survival after breast cancer diagnosis is less clear.
METHODS: We investigated whether alcohol intake was associated with survival among 3146 women diagnosed with invasive breast
cancer in the Swedish Mammography Cohort. Alcohol consumption was estimated using a food frequency questionnaire.
Cox proportional hazard models were used to calculate hazard ratios (HRs) and 95% confidence intervals (95% CIs).
RESULTS: From 1987 to 2008 there were 385 breast cancer-specific deaths and 860 total deaths. No significant association was
observed between alcohol intake and breast cancer-specific survival. Women who consumed 10g per day (corresponding
to approximately 0.75 to 1 drinks) or more of alcohol had an adjusted HR (95% CI) of breast cancer-specific death of 1.36
(0.82–2.26;ptrend¼0.47) compared with non-drinkers. A significant inverse association was observed between alcohol and non-
breast cancer deaths. Those who consumed 3.4–9.9g per day of alcohol had a 33% lower risk of death compared with non-drinkers
(95% CI 0.50–0.90;ptrend¼0.04).
CONCLUSION: Our findings suggest that alcohol intake up to approximately one small drink per day does not negatively impact
breast cancer-specific survival and a half drink per day is associated with a decreased risk of mortality from other causes.
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Alcohol intake has consistently been associated with increased
breast cancer risk in epidemiological studies. (Smith-Warner et al,
1998; AICR, 2007) In contrast to the increased risk observed with
breast cancer incidence, most studies examining survival after
breast cancer diagnosis have either reported an inverse association
between pre- and post-diagnosis alcohol consumption and
all-cause survival (Barnett et al, 2008; Reding et al, 2008; Beasley
et al, 2010; Flatt et al, 2010) or no association. (Ewertz et al, 1991;
Zhang et al, 1995; Holmes et al, 1999; Saxe et al, 1999; McEligot
et al, 2006; Franceschi et al, 2009; Kwan et al, 2010). When breast
cancer-specific outcomes have been examined, four studies have
reported an increased risk with breast cancer-specific mortality or
recurrence (Hebert et al, 1998; Green McDonald et al, 2002;
Beasley et al, 2010; Kwan et al, 2010), and two studies reported no
association (Rohan et al, 1993; Goodwin et al, 2003). Given these
inconclusive results, the aim of this study was to investigate
whether pre-diagnosis alcohol intake was associated with breast
cancer-specific and overall survival among women with invasive
breast cancer in the population-based Swedish Mammography
Cohort (SMC). We also examined whether the association between
alcohol and survival differed by hormone receptor status, disease
stage at diagnosis, or folate intake.
MATERIALS AND METHODS
Study population
This study included 3146 participants in the SMC with invasive
breast cancer diagnosed between 1987 and 2008. Recruitment and
characteristics of this cohort have been previously described
(Wolk et al, 2006). In brief, the SMC is a population-based cohort
of 66651 women born between 1914 and 1948 that were recruited
between 1987 and 1990 in Va ¨stmanland and Uppsala counties in
central Sweden. A total of 66651 women (74% of the source
population) returned the baseline questionnaire with questions
regarding diet, reproductive factors, body size, and other factors.
In 1997, a second questionnaire was sent to 56030 participants
who were still alive and residing in the study area; 39227 (70%)
women returned this questionnaire. Those with an incorrect or
missing national registration number, previous cancer diagnosis
(except non-melanoma skin cancer), and with implausible total
energy intake (three standard deviations (s.d.) from the mean
value for loge-transformed energy intake) were excluded from the
baseline cohort. The study was approved by the ethics committees
at the Uppsala University Hospital (Uppsala, Sweden) and the
Karolinska Institutet (Stockholm, Sweden).
Histologically confirmed incident invasive breast cancer cases
were ascertained by linkage of the study cohort with Swedish
Cancer registers. Estrogen (ER) and progesterone (PR) receptor
status and other clinical characteristics were obtained by reviewing
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ypathology laboratory works logs from Uppsala University Hospital
(1987–1994) and by linkage with the clinical database (Quality
Register) at the Regional Oncology Centre in Uppsala (1992–2008),
which was based on the patient’s original medical records. ER and
PR status, menopausal status at diagnosis, tumor size, grade,
lymph node involvement, and type of treatment were available for
approximately 77% of the cases. More detailed information on the
evaluation of ER and PR status in this cohort has been described
previously (Larsson et al, 2009).
Dietary assessment
Diet was assessed using a 67-item food frequency questionnaire
(FFQ) at baseline and a 96-item FFQ in 1997. Participants were
asked how often, on average, they had consumed alcohol during
the previous 6 months (1987) or year (1997). Eight responses were
possible ranging from never or seldom to four, or more times
per day. Alcohol intake was calculated by multiplying the
reported frequency of consumption by age-specific drinks sizes
(Suzuki et al, 2005). The FFQ has been previously validated among
129 cohort participants and the correlation coefficient between the
questionnaire and four 1-week dietary records was 0.9 for alcohol
(A Wolk, 1992, unpublished data).
Outcome assessment
Date of death was identified through linkage of the study cohort to
the Swedish National Death Registry at Statistics Sweden. Cause of
death was determined by International Classification of Diseases
(ICD) codes (ICD9 and ICD10) through linkage to the Cause of
Death Registry at the National Board of Health and Welfare.
Statistical analysis
We used Cox proportional hazard models with time since
diagnosis in months as the time scale to calculate hazard ratios
(HRs) and 95% confidence intervals (95% CIs) for death from
breast cancer (primary endpoint), death from other causes, or
death from any cause as the endpoints, depending on the analysis.
Participants contributed person-time from the date of breast
cancer diagnosis until the death from breast cancer, death from
another cause, or end of follow-up on 31 December 2008. Baseline
diet (1987) was considered the exposure in all analyses except
when dietary change was examined. Alcohol consumption
was divided into four categories: non-drinker (reference), o3.4,
3.4–9.9, and X10g per day. The cut points of 3.4 and 10g per day
correspond to the median value among drinkers in the full SMC
and to approximately one alcoholic drink, respectively (Suzuki
et al, 2005). Total caloric intake (continuous) and age at diagnosis
(continuous) were included in all models.
Models were adjusted a priori for total caloric intake, age at
diagnosis, education level (primary school, high school, univer-
sity), marital status (single, married, divorced, widowed, living
with partner), menopausal status at diagnosis (premenopausal,
postmenopausal, unknown), body mass index (BMI) (o20,
20–24.9, 25–29.9, X30kgm
 2), and calendar year of diagnosis
(continuous). We considered parity, age at first birth, oral
contraceptive use, postmenopausal hormone use, height, and
family history of breast cancer to be potential confounders if their
addition to the model changed the HR by at least 10%. Based on
these criteria they were not observed to be confounders and
therefore were not included in the final models. Additional
multivariable models considered adjustment for clinical character-
istics: stage (I, II, III, IV), grade (I, II, III), radiation treatment
(yes/no), and chemotherapy/hormonal therapy (no chemotherapy
or hormonal therapy, hormonal therapy and no chemotherapy,
chemotherapy and no hormonal therapy, hormonal therapy and
chemotherapy).
We examined whether the association between alcohol and
breast cancer survival differed by hormone receptor status, disease
stage at diagnosis, or folate intake with a likelihood ratio test
comparing the model with the cross-product term between alcohol
and each potential effect modifier to the model with main effects
only. All tests of statistical significance were two-sided, and
all statistical analyses were performed using SAS Version 9.2
(SAS Institute Inc., Cary, NC, USA).
RESULTS
During 25940 person-years of follow-up from 1987 to 2008 there
were 860 total deaths and 385 breast cancer deaths among 3146
breast cancer cases. Thirty percent of participants were non-
drinkers and the median alcohol intake among the drinkers was
3.0g per day. The distribution of participant characteristics by
alcohol intake are shown in Table 1. Women with the highest
intake of alcohol were more likely to have a postsecondary
education and to be married, were less often nulliparous, and had
the lowest mean BMI. Of those with ER and PR status available
62% were ERþ/PRþ, 20% were ERþ/PR , 5% were ER /PRþ,
and 13% ER /PR .
No significant association was observed between alcohol intake
and breast cancer-specific mortality (Table 2). Women who
consumed 10 or more g per day of alcohol had a covariate-
adjusted HR (95% CI) of breast cancer death of 1.09 (0.66–1.81)
compared with non-drinkers (ptrend¼0.87) and a covariate and
clinical-characteristics adjusted HR (95% CI) of 1.36 (0.82–2.26;
ptrend¼0.47). When death from a cause other than breast cancer
was considered the endpoint there was a statistically significant
decrease in risk that was strongest among moderate drinkers.
Those who consumed 3.4–9.9g per day of alcohol had a 33% lower
risk of non-breast cancer-related death compared with non-
drinkers (95% CI 0.50–0.90; ptrend¼0.04). This reduction in risk
was not statistically significant for women consuming 10 or more g
per day of alcohol; however, there were few women in this
subgroup (HR¼0.81; 95% CI 0.46–1.43). The association between
alcohol intake and mortality did not vary by the hormone receptor
status of the tumor, disease stage at diagnosis or folate intake (data
not shown). When analyses were restricted to postmenopausal
women at diagnosis results were similar to the full analytic sample.
We examined dietary change following breast cancer diagnosis
among the 717 breast cancer cases who were diagnosed with breast
cancer from 1987–1996 and completed a FFQ in 1997 after their
breast cancer diagnosis. Over 92% remained in the same or
adjacent category of alcohol intake following their breast cancer
diagnosis. However, numbers were too small to examine the
association between post-diagnosis alcohol intake and survival in
this group.
DISCUSSION
In this population-based prospective study of Swedish women with
breast cancer, alcohol consumption was not significantly asso-
ciated with breast cancer-specific mortality, whereas moderate
intake was associated with a decreased risk of mortality from
causes other than breast cancer.
Alcohol intake is well established as a risk factor for breast
cancer occurrence (Smith-Warner et al, 1998; AICR, 2007). The
biological mechanism through which it increases breast cancer risk
is most likely through increases in ER levels (Dorgan et al, 2001;
Singletary and Gapstur, 2001; Dumitrescu and Shields, 2005).
Alcohol intake has the potential to influence survival through a
similar mechanism as a number of breast cancer treatments
include anti-ER therapy, and some studies have shown that
hormone replacement therapy may increase breast cancer
recurrence (Ewertz et al, 1991; Kenemans et al, 2009). However,
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ystudies examining alcohol intake and survival after breast cancer
have not consistently demonstrated a similar unfavorable effect.
This may be in part because they have used various endpoints to
examine survival (Holmes, 2010). With all-cause mortality as the
endpoint seven studies reported no association (Ewertz et al, 1991;
Zhang et al, 1995; Holmes et al, 1999; Saxe et al, 1999; McEligot
et al, 2006; Franceschi et al, 2009; Kwan et al, 2010) and four
studies reported an inverse association between alcohol consump-
tion and overall survival (Barnett et al, 2008; Reding et al, 2008;
Beasley et al, 2010; Flatt et al, 2010). In contrast, when the
endpoint was breast cancer-specific mortality or breast cancer
recurrence, two studies reported no association (Rohan et al, 1993;
Goodwin et al, 2003), while four studies reported an increase in
risk with increasing alcohol consumption (Hebert et al, 1998;
Green McDonald et al, 2002; Beasley et al, 2010; Kwan et al, 2010).
We observed no significant association between alcohol intake and
breast cancer-specific mortality, although there was the suggestion
of an increased risk among the small number of women
consuming 10g per day (corresponding to approximately 0.75
to 1 drink/day) or more (HR¼1.36; 95% CI 0.82–2.26) (Suzuki
et al, 2005).
In contrast to our results for breast cancer-specific mortality, we
observed a decrease in risk for mortality from causes other than
breast cancer that was strongest for moderate drinkers (those
consuming on average approximately a half drink per day). These
results are consistent with the observation that while moderate
alcohol intake reduces the risk of cardiovascular disease mortality,
heavier drinking may increase the risk of death from breast cancer
(Fuchs et al, 1995).
Our study was limited by a single pre-diagnosis assessment of
diet in the majority of our participants, which did not allow for us
to examine post-diagnosis diet during the follow-up period.
However, when we examined dietary change in the subset of
breast cancer cases who completed a FFQ post-diagnosis, over 92%
remained in the same or adjacent category of alcohol intake
following diagnosis. In addition, measurement error was possible
in our assessment of dietary intake as it was collected via a self-
administered FFQ and alcohol portion size was not assessed on
the 1987 FFQ. However, the FFQ has been previously validated
with diet records with a correlation of 0.9 for alcohol (A Wolk,
unpublished data, 1992) and any errors in this measurement would
likely cause an attenuation of the true effect. Another limitation of
Table 1 Characteristics of 3146 women with invasive breast cancer in
the Swedish Mammography Cohort by alcohol intake
a
Alcohol intake (g per day)
Non-
drinker o3.4 3.4–9.9 X10
Median alcohol intake (g per day) 0 1.8 5.0 12.4
Age at enrollment (years) 56.8 53.0 49.9 48.4
Age at diagnosis (years) 68.2 64.9 62.6 61.4
Postsecondary education (%) 8.3% 12.4% 14.2% 18.2%
Married (%) 68.1% 69.8% 71.9% 82.8%
Body mass index (kgm
 2) 26.3 24.9 23.9 23.6
Height (cm) 163.5 164.8 165.3 165.8
Age at menarche (years) 13.3 13.2 13.1 13.3
Nulliparous (%) 14.4% 13.2% 11.4% 10.9%
Age at first birth among parous
women (years)
24.6 24.5 24.8 25.1
Number of children 2.4 2.2 2.2 2.1
Family history of breast cancer (%) 13.2% 10.8% 11.2% 9.7%
Ever use of oral contraceptives (%) 35.2% 43.4% 51.5% 56.9%
Postmenopausal at diagnosis (%)
b 93.9% 89.7% 88.6% 89.7%
Total energy intake (kcal per day) 1575 1571 1610 1620
Stage I (%) 48.5% 52.4% 53.4% 60.3%
Treatment (%)
b,c
Radiation 47.3% 58.4% 62.5% 63.6%
Chemotherapy 10.5% 16.2% 18.4% 19.4%
Hormonal 33.2% 34.4% 37.5% 37.0%
Estrogen receptor positive (%)
b 81.2% 81.3% 82.5% 86.1%
Progesterone receptor positive (%)
b 69.5% 68.4% 63.9% 61.7%
aData represent mean unless otherwise indicated. Percents may not equal 100 due to
missing values.
bMenopausal status at diagnosis, ER and PR status, and type of
treatment were available for 77% of the cases.
cGreater than 100% because some
breast cancer patients receive more than one treatment.
Table 2 Hazard ratios (HR) and 95% confidence intervals (95% CI) of death by categories of alcohol intake among 3146 invasive breast cancer cases in
the Swedish Mammography Cohort
Alcohol intake (g per day)
Non-drinker o3.4 3.4–9.9 X10 Ptrend
a
Median alcohol intake (g per day) 0 1.8 5.0 12.4
Person-years 7714 10431 6515 1280
Breast cancer deaths 133 149 85 18
Age-adjusted model 1.00 0.85 (0.68–1.08) 0.79 (0.60–1.05) 0.85 (0.51–1.39) 0.26
Covariate-adjusted model
b 1.00 0.93 (0.73–1.18) 0.94 (0.70–1.25) 1.09 (0.66–1.81) 0.87
Covariate-adjusted model+clinical characteristics
c 1.00 0.95 (0.74–1.21) 0.94 (0.70–1.25) 1.36 (0.82–2.26) 0.47
Non-breast cancer deaths 224 172 66 13
Age-adjusted model 1.00 0.74 (0.61–0.91) 0.65 (0.49–0.85) 0.77 (0.44–1.35) 0.01
Covariate-adjusted model
b 1.00 0.76 (0.62–0.93) 0.66 (0.50–0.89) 0.79 (0.45–1.29) 0.03
Covariate-adjusted model+clinical characteristics
c 1.00 0.77 (0.73–0.95) 0.67 (0.50–0.90) 0.81 (0.46–1.43) 0.04
Total deaths 357 321 151 31
Age-adjusted model 1.00 0.79 (0.68–0.92) 0.71 (0.59–0.87) 0.80 (0.56–1.16) 0.01
Covariate-adjusted model
b 1.00 0.83 (0.71–0.97) 0.79 (0.64–0.96) 0.92 (0.63–1.34) 0.16
Covariate-adjusted model+clinical characteristics
c 1.00 0.85 (0.73–1.00) 0.80 (0.65–0.98) 1.03 (0.71–1.51) 0.36
aDetermined using category medians.
bCox proportional hazard model adjusted for age (continuous), energy intake (continuous), education level (primary, high school,
university), marital status (single, married, divorced, widowed, living with partner), menopausal status at diagnosis (premenopausal, postmenopausal, unknown), body mass
index (o20, 20–24.9, 25–29.9, X30kgm
 2), and calendar year of diagnosis (continuous).
cCox proportional hazard model adjusted for the variables above plus disease stage
(I, II, III/IV), grade (I, II, III), radiation treatment (yes/no), and chemotherapy and/or hormonal treatment (no chemotherapy or hormonal treatment, hormonal therapy and no
chemotherapy, chemotherapy and no hormonal therapy, and hormonal therapy and chemotherapy).
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your study was the low consumption of alcohol in our population,
which may have limited our ability to detect a significant
association between higher levels of alcohol intake and breast
cancer-specific mortality. The mean alcohol intake in the SMC is
3.2g per day, which is much lower than other prospective cohorts
consisting of healthy women at baseline that have reported means
ranging from 5.5–12.6g per day (Smith-Warner et al, 1998).
Finally, we only had ER and PR status, menopausal status at
diagnosis, tumor size, grade, lymph node involvement, and type of
treatment information for 77% of our cases.
Our study has several strengths including use of breast cancer
cases diagnosed within a prospective population-based cohort,
complete follow-up of all cases, and a relatively large number
of total deaths (n¼860), including 385 breast cancer deaths.
This large sample size allowed us the power to examine breast
cancer-specific mortality as well as how the association differed
by hormone receptor status and stage at diagnosis.
In conclusion, our findings suggest that alcohol intake at the
level of up to approximately one small drink per day does not
negatively impact breast cancer-specific survival and is inversely
associated with non-breast cancer death. These results are
consistent with the World Cancer Research Fund/American
Institute for Cancer Research recommendation that if alcohol
drinks are consumed at all, alcohol consumption should be limited
to no more than one small drink a day for women (AICR, 2007).
The association between alcohol intake and breast cancer specific-
mortality should be further evaluated in populations with a wider
range of alcohol consumption.
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